CH466894A - Verfahren zur Herstellung eines Vakzins gegen infektiöse Gastroenteritis - Google Patents

Verfahren zur Herstellung eines Vakzins gegen infektiöse Gastroenteritis

Info

Publication number
CH466894A
CH466894A CH1226365A CH1226365A CH466894A CH 466894 A CH466894 A CH 466894A CH 1226365 A CH1226365 A CH 1226365A CH 1226365 A CH1226365 A CH 1226365A CH 466894 A CH466894 A CH 466894A
Authority
CH
Switzerland
Prior art keywords
preparation
vaccine against
against infectious
infectious gastroenteritis
gastroenteritis
Prior art date
Application number
CH1226365A
Other languages
English (en)
Inventor
Joseph Welter Clarence
Original Assignee
Diamond Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diamond Lab Inc filed Critical Diamond Lab Inc
Publication of CH466894A publication Critical patent/CH466894A/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A61K39/225—Porcine transmissible gastroenteritis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20061—Methods of inactivation or attenuation
    • C12N2770/20064—Methods of inactivation or attenuation by serial passage

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CH1226365A 1964-09-22 1965-09-02 Verfahren zur Herstellung eines Vakzins gegen infektiöse Gastroenteritis CH466894A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39839864A 1964-09-22 1964-09-22

Publications (1)

Publication Number Publication Date
CH466894A true CH466894A (de) 1968-12-31

Family

ID=23575249

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1226365A CH466894A (de) 1964-09-22 1965-09-02 Verfahren zur Herstellung eines Vakzins gegen infektiöse Gastroenteritis

Country Status (10)

Country Link
BE (1) BE669881A (de)
CH (1) CH466894A (de)
DE (1) DE1253412B (de)
DK (1) DK109407C (de)
FR (1) FR1563628A (de)
GB (1) GB1058340A (de)
LU (1) LU49501A1 (de)
NL (1) NL6512094A (de)
NO (1) NO119491B (de)
SE (1) SE358657B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3519710A (en) * 1967-08-10 1970-07-07 Edmund P Bass Direct active modified live virus vaccine immunization against transmissible gastroenteritis in swine piglets at birth
US5911999A (en) * 1987-09-28 1999-06-15 Pfizer, Inc. Vaccine based on TGEV for protection of dogs against canine coronavirus
DK175379B1 (da) * 1987-09-28 2004-09-20 Pfizer Anvendelse af transmitterbart svine-gastro-enteritisvirus samt fremgangsmåde til fremstilling af en vaccine
US6074651A (en) * 1988-09-14 2000-06-13 Pfizer, Inc. Vaccine based on TGEV for protection of canines against canine coronavirus

Also Published As

Publication number Publication date
FR1563628A (de) 1969-04-18
BE669881A (de) 1966-03-21
NO119491B (de) 1970-05-25
NL6512094A (de) 1966-03-23
GB1058340A (en) 1967-02-08
SE358657B (de) 1973-08-06
DE1253412B (de) 1967-11-02
DK109407C (da) 1968-04-22
LU49501A1 (de) 1966-03-21

Similar Documents

Publication Publication Date Title
AT295863B (de) Verfahren zur Herstellung eines Stabilisierungsmittels
AT287196B (de) Verfahren zur Herstellung eines neuen Impfstoffes gegen Mastitis
AT282824B (de) Verfahren zur Herstellung einer neuen Adjuvansvaccine
AT265526B (de) Verfahren zur Herstellung eines Desinfektionsmittels
CH472368A (de) Verfahren zur Herstellung eines sekundären Aralkylamins
CH469093A (de) Verfahren zur Herstellung eines neuen Impfstoffes gegen Panleucopenia
AT279816B (de) Verfahren zur Herstellung eines neuen Dekapeptids
CH451915A (de) Verfahren zur Herstellung eines neuen Amins
CH439274A (de) Verfahren zur Herstellung eines Cyclopentenonderivates
CH483468A (de) Verfahren zur Herstellung eines härtbaren Gemisches
AT285065B (de) Verfahren zur Herstellung eines neuen Pentacosapeptids
CH466894A (de) Verfahren zur Herstellung eines Vakzins gegen infektiöse Gastroenteritis
CH453176A (de) Verfahren zur Herstellung eines Leuchtsatzes
AT261122B (de) Verfahren zur Herstellung eines Desinfektionsmittels
CH442298A (de) Verfahren zur Herstellung eines Piperidin-Derivates
CH484172A (de) Verfahren zur Herstellung eines neuen Oxazolidinons
AT273636B (de) Verfahren zur Herstellung eines Präparates mit Fleischgeschmack
AT259760B (de) Verfahren zur Herstellung von Influenzavaccinen
AT251576B (de) Verfahren zur Herstellung eines 2-Nitroimidazols
AT285044B (de) Verfahren zur Herstellung einer somatischen Antigenvaccine
AT279038B (de) Verfahren zur Herstellung eines Impfstoffes gegen Röteln
AT265517B (de) Verfahren zur Herstellung einer Vaccine gegen Staupe
CH473081A (de) Verfahren zur Herstellung eines Nickelchelats von 1-Nitro-so-2-naphthol
CH472403A (de) Verfahren zur Herstellung eines 4'-Demethyl-epipodophyllotoxins
AT297920B (de) Verfahren zur Herstellung eines Arzneimittels